OA
Healthcare & Life Sciences
Okairos AG
Switzerland
Okairos AG is a Healthcare & Life Sciences startup based in Switzerland, most recent round Series B, 1 tracked investor.
series-b
series-b
Stage
1
Investors
About Okairos AG
Based in Switzerland, Okairos AG is a startup. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Okairos AG was a biotechnology company developing viral-vectored vaccines using adenoviral and modified vaccinia Ankara (MVA) platforms to induce strong T-cell responses for infectious diseases and immunotherapy.
Explore Okairos AG's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.